Skip to content

Nasal Cannula Versus Single Nasal Prong for Non-Invasive Ventilation in Preterm Infants

Nasal Cannula Versus Single Nasal Prong for Non-Invasive Ventilation in Preterm Infants After Birth: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07725614
Enrollment
140
Registered
2026-07-24
Start date
2026-07-20
Completion date
2027-07-20
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Brief summary

Preterm infants frequently require non-invasive ventilation (NIV) to treat respiratory distress after birth. The effectiveness of NIV may be influenced by the interface used to deliver respiratory support. Nasal cannula and single nasal prong are two interfaces commonly used for NIV; however, evidence directly comparing their efficacy during the early postnatal period remains limited. This randomized controlled trial aims to compare the efficacy of a nasal cannula and a single nasal prong as interfaces for non-invasive ventilation in preterm infants after birth. Eligible preterm infants requiring NIV after initial stabilization will be randomly assigned to receive respiratory support using either a nasal cannula or a single nasal prong. The assigned interface will be maintained for one hour following randomization, including during transport from the delivery room to the neonatal intensive care unit. The primary outcome is the need for endotracheal intubation within one hour after interface application. Secondary outcomes include the need for endotracheal intubation within 6 hour of age, respiratory effectiveness, assessed by the oxygen saturation index (OSI) and arterial blood gas parameters (pH and partial pressure of carbon dioxide \[pCO₂\]), as well as interface-related adverse events, including interface dislodgement and nasal injury. This study is expected to provide evidence to support the selection of an effective non-invasive ventilation interface for preterm infants after birth.

Interventions

DEVICEExperimental, Intervention Name: Nasal Cannula

Non-invasive ventilation delivered through a nasal cannula as the respiratory interface for one hour after randomization in preterm infants after birth.

DEVICEActive comparator: single nasal prong

Non-invasive ventilation delivered through a single nasal prong as the respiratory interface for one hour after randomization in preterm infants after birth.

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

Inclusion Criteria: 1. Preterm infants with a gestational age of 28 to \<37 weeks who develop respiratory distress and require non-invasive ventilation (NIV) after birth. 2. Written informed consent is obtained from a parent or legal guardian.

Exclusion criteria

1. Infants with congenital nasal defects, including cleft lip and palate. 2. Infants with prenatally diagnosed congenital anomalies that contraindicate NIV, including congenital diaphragmatic hernia, choanal atresia, esophageal atresia with tracheoesophageal fistula, or congenital heart disease. 3. Infants with multiple congenital anomalies. 4. Infants requiring endotracheal intubation for positive pressure ventilation immediately after birth.

Design outcomes

Primary

MeasureTime frameDescription
The need for endotracheal intubationWithin 1 hour after interface application.The proportion of preterm infants requiring endotracheal intubation during the first hour after application of the assigned non-invasive ventilation interface.

Secondary

MeasureTime frameDescription
The need for Endotracheal IntubationBy 6 hours of ageThe proportion of preterm infants requiring endotracheal intubation by 6 hours of age.
Oxygen Saturation Index (OSI)At 1 hour after interface applicationOxygen saturation index measured to assess respiratory effectiveness after 1 hour application of the assigned non-invasive ventilation interface.
Partial Pressure of Carbon Dioxide (pCO₂)At 1 hour after interface applicationPartial pressure of carbon dioxide (pCO₂) measured to evaluate ventilatory effectiveness at 1 hour after application of the assigned non-invasive ventilation interface.
Blood pHAt 1 hour after interface applicationBlood pH measured to evaluate oxygenation effectiveness at 1 hour after application of the assigned non-invasive ventilation interface.
Interface DislodgementWithin 1 hour after interface applicationThe proportion of infants experiencing dislodgement of the assigned non-invasive ventilation interface during the first hour after interface application.
Title Nasal InjuryAt 1 hour after interface applicationDescription The proportion of infants developing nasal injury associated with the assigned non-invasive ventilation interface during the first hour after interface application.

Countries

Indonesia

Contacts

CONTACTRaden Adhi Teguh Perma Iskandar, Principal Investigator
adhitpi@gmail.com085779153162
CONTACTIna Rochayati
inarochayati@gmail.com087712526805

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026